Literature DB >> 22008819

Horizontal transmission of a human rotavirus vaccine strain--a randomized, placebo-controlled study in twins.

Luis Rivera1, Lourdes Mendez Peña, Isabelle Stainier, Paul Gillard, Brigitte Cheuvart, Igor Smolenov, Eduardo Ortega-Barria, Htay Htay Han.   

Abstract

Transmission of excreted vaccine-derived infectious virus from vaccinated to unvaccinated individuals is possible within close contacts. This randomized (1:1), double-blind study evaluated the potential for transmission of human rotavirus vaccine strain, HRV (Rotarix™) from vaccine recipients to unvaccinated close contacts (twins). 100 pairs of healthy twins aged 6-14 weeks at the time of Dose 1 of HRV vaccine/placebo were enrolled and one randomly selected twin from each pair received two vaccine doses and the other received placebo doses (at 2 and 4 months of age). Presence of vaccine strain in the stool samples of placebo recipients was an indicator of transmission. Serial stool samples were tested for rotavirus using ELISA at pre-determined time points; rotavirus positive stool samples were tested with RT-PCR and reverse hybridization assay to identify G1P[8] vaccine strain. If G1P[8] vaccine strain was detected, the complete genome was sequenced to assess the similarity between viral isolates. Immunogenicity and safety of HRV vaccine in transmission cases was assessed. 15 transmission cases were reported in 80 evaluable twins who received placebo and the transmission rate was 18.8% (95% CI: 10.9-29.0%). None of the transmission cases was associated with gastroenteritis symptoms. Anti-rotavirus IgA seroconversion was 62.5% (95% CI: 51.0-73.1%) (HRV) and 21.3% (95% CI: 12.9-31.8%) (placebo) 7-weeks post-Dose 2; seroconversion in transmission cases was 26.7% (95% CI: 7.8-55.1%). Genetic variations or amino acid substitutions in transmission cases were similar to that seen in corresponding vaccine recipients. Transmission of HRV vaccine strain to unvaccinated twins living in close contact occurred, however, they were not associated with increased of gastroenteritis. Whether transmission leads to indirect protection among unvaccinated individuals remains unknown at this stage.
Copyright © 2011. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22008819     DOI: 10.1016/j.vaccine.2011.10.015

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  25 in total

1.  An infant with acute gastroenteritis caused by a secondary infection with a Rotarix-derived strain.

Authors:  Naomi Sakon; Ryohei Miyamoto; Jun Komano
Journal:  Eur J Pediatr       Date:  2017-07-21       Impact factor: 3.183

2. 

Authors:  Norbert Wagner; Frauke Assmus; Gabriele Arendt; Erika Baum; Ulrich Baumann; Christian Bogdan; Gerd Burchard; Dirk Föll; Edeltraut Garbe; Jane Hecht; Ulf Müller-Ladner; Tim Niehues; Klaus Überla; Sabine Vygen-Bonnet; Thomas Weinke; Miriam Wiese-Posselt; Michael Wojcinski; Fred Zepp
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2019-04       Impact factor: 1.513

3.  Horizontal transmission of live vaccines.

Authors:  Prasad S Kulkarni; Suresh S Jadhav; Rajeev M Dhere
Journal:  Hum Vaccin Immunother       Date:  2013-01       Impact factor: 3.452

4.  Rotavirus shedding following administration of RV3-BB human neonatal rotavirus vaccine.

Authors:  Daniel Cowley; Karen Boniface; Nada Bogdanovic-Sakran; Carl D Kirkwood; Julie E Bines
Journal:  Hum Vaccin Immunother       Date:  2017-05-08       Impact factor: 3.452

5.  Symptomatic infection and detection of vaccine and vaccine-reassortant rotavirus strains in 5 children: a case series.

Authors:  Julie A Boom; Leila C Sahni; Daniel C Payne; Rashi Gautam; Freda Lyde; Slavica Mijatovic-Rustempasic; Michael D Bowen; Jacqueline E Tate; Marcia A Rench; Jon R Gentsch; Umesh D Parashar; Carol J Baker
Journal:  J Infect Dis       Date:  2012-08-07       Impact factor: 5.226

6.  Detection and Clinical Implications of Monovalent Rotavirus Vaccine-Derived Virus Strains in Children with Gastroenteritis in Alberta, Canada.

Authors:  Ran Zhuo; Gillian A M Tarr; Jianling Xie; Stephen B Freedman; Daniel C Payne; Bonita E Lee; Charlotte McWilliams; Linda Chui; Samina Ali; Xiaoli Pang
Journal:  J Clin Microbiol       Date:  2021-08-18       Impact factor: 5.948

7.  Detection of PCV-2 DNA in stool samples from infants vaccinated with RotaTeq®.

Authors:  Mathew D Esona; Slavica Mijatovic-Rustempasic; Catherine Yen; Umesh D Parashar; Jon R Gentsch; Michael D Bowen; Philip LaRussa
Journal:  Hum Vaccin Immunother       Date:  2013-10-08       Impact factor: 3.452

8.  Effect of breastfeeding on immunogenicity of oral live-attenuated human rotavirus vaccine: a randomized trial in HIV-uninfected infants in Soweto, South Africa.

Authors:  Michelle J Groome; Sung-Sil Moon; Daniel Velasquez; Stephanie Jones; Anthonet Koen; Nadia van Niekerk; Baoming Jiang; Umesh D Parashar; Shabir A Madhi
Journal:  Bull World Health Organ       Date:  2014-02-04       Impact factor: 9.408

9.  Vaccines for preventing rotavirus diarrhoea: vaccines in use.

Authors:  Karla Soares-Weiser; Hanna Bergman; Nicholas Henschke; Femi Pitan; Nigel Cunliffe
Journal:  Cochrane Database Syst Rev       Date:  2019-10-28

10.  Effectiveness of monovalent rotavirus vaccine in Bolivia: case-control study.

Authors:  Manish M Patel; Maritza Patzi; Desiree Pastor; Aleida Nina; Yelin Roca; Leovigildo Alvarez; Volga Iniguez; Rosario Rivera; Ka Ian Tam; Osbourne Quaye; Michael Bowen; Umesh Parashar; Lucia Helena De Oliveira
Journal:  BMJ       Date:  2013-06-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.